RCM images were captured with Vivascope 1500®; MAVIG GmbH, Munich, Germany. RCM instrumental and acquisition methods were previously described elsewhere [13]. To ensure the capture of RCM images in precisely the same location throughout the study period, an area was designated on a piece of transparent paper for each patient. Briefly, for each macule, a complete set of ≥3 Viva-Block mosaics (epidermal layers, the dermo-epidermal junction [DEJ], and the upper dermis) was captured. RCM features of interest were predefined, according to those identified by Ciardo et al., as both diagnostic and ideal for skin response: the presence/absence of (i) blood vessels, (ii) dendritic cells, and the quantity of (i) an irregular honeycombed pattern and (ii) pigmented papillae [25]. Follow-up/post-treatment investigations were performed via telephone with the patients at 10 and 12 months from treatment initiation.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.